Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Gilead Sciences: Debt Fueled Bottom [Seeking Alpha]

IMMUNOMEDICS (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
Company Research Source: Seeking Alpha
SummaryGilead Sciences paid a hefty premium for Immunomedics.The breast cancer drug deal is expected to be accretive to EPS by 2023.The market wasn't fond hearing of the potential for more deals after the biopharma has loaded up on debt already.The stock is cheap at 9x forward earnings with a potentially accretive deal on the books now.Despite the excitement surrounding Remdesivir as a treatment for COVID-19,GILDIMMUinvestment thesisImage Source: Trodelvy websiteDeal Detailsagreed to pay $88approval for TrodelvyThe transaction details suggested Gilead would pay ~$15 billion in existing cash and raise $6 billion in additional debt. The company justraised $7.25 billionNaturally, the cash deal is easily accretive on an EPS basis in a low interest rate environment where debt isn't very expensive costing only 1-2% per annum. The problem is that the accretive nature of the deal isn't necessarily warranting of a $21 billion purchase price. In total, analysts have the company only generating Show less Read more
Impact Snapshot
Event Time:
IMMU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMMU alerts
Opt-in for
IMMU alerts

from News Quantified
Opt-in for
IMMU alerts

from News Quantified